Bioavailability Contract Manufacturing Drug Delivery Systems 
Roots Analysis
FEBRUARY 20, 2022
Over the last decade, one of the major challenges faced by pharmaceutical players across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical products approved by regulatory organizations exhibit poor bioavailability / solubility. Nanoparticles Contract Manufacturing.
Roots Analysis
MARCH 13, 2022
Therefore, a variety of excipients, which are pharmacologically inert substances themselves, are used to stabilize biologics during the manufacturing process and storage. For more details on this emerging domain, check out the following report : Exosome Development and Manufacturing Services Market. Our Social Media Platform.
Expert insights. Personalized for you.
52 
Let's personalize your content